Dietary Restriction (DR) mitigates loss of proteostasis associated with aging that underlies neurodegenerative conditions including Alzheimer's disease and related dementias. Previously, we observed increased translational efficiency of certain FMRFamide-Like neuro-Peptide (<i>FLP</i>) genes and the neuroprotective growth factor progranulin gene <i>
prgn-1</i> under dietary restriction in <i>C. elegans</i>. Here, we tested the effects of <i>
flp-5</i>, <i>
flp-14</i>, <i>
flp-15</i> and <i>
pgrn-1</i> on lifespan and proteostasis under both standard and dietary restriction conditions. We also tested and distinguished function based on their expression in either neuronal or non-neuronal tissue. Lowering the expression of <i>
pgrn-1</i> and flp genes selectively in neural tissue showed no difference in survival under normal feeding conditions nor under DR in two out of three experiments performed. Reduced expression of <i>
flp-14</i> in non-neuronal tissue showed decreased lifespan that was not specific to DR. With respect to proteostasis, a genetic model of DR from mutation of the <i>
eat-2</i> gene that showed increased thermotolerance compared to fully fed wild type animals demonstrated no change in thermotolerance in response to knockdown of <i>
pgrn-1</i> or <i>flp</i> genes. Finally, we tested effects on motility in a neural-specific model of proteotoxicity and found that neuronal knockdown of <i>
pgrn-1</i> and <i>flp</i> genes improved motility in early life regardless of diet. However, knocking these genes down in non-neuronal tissue had variable results. RNAi targeting <i>
flp-14</i> increased motility by day seven of adulthood regardless of diet. Interestingly, non-neuronal RNAi of <i>
pgrn-1</i> decreased motility under standard feeding conditions while DR increased motility for this gene knockdown by day seven (early mid-life). Results show that <i>
pgrn-1</i>, <i>
flp-5</i>, <i>
flp-14</i>, and <i>
flp-15</i> do not have major roles in diet-related changes in longevity or whole-body proteostasis. However, reduced expression of these genes in neurons increases motility early in life in a neural-specific model of proteotoxicity, whereas knockdown of non-neuronal expression mostly increases motility in mid-life under the same conditions.